The Runt related transcription factors (RUNX) are recognized as key players in suppressingor promoting tumor growth. RUNX3, a member of this family, is known as a tumor suppressorin many types of cancers, although such a paradigm was challenged by some researchers. TheTGF-β pathway governs major upstream signals to activate RUNX3. RUNX3 protein consistsof several regions and domains. The Runt domain is a conserved DNA binding domain andis considered as the main part of RUNX proteins. Herein, we compared the effects of Runtdomains and full-Runx3 in cell viability by designing two constructs of Runx3, includingN-terminal region and Runt domain. We investigated the effect of full-Runx3, N-t, and RD ongrowth inhibition in AGS, MCF-7, A549, and HEK293 cell lines which are different in TGF-β sensitivity, in the absence and presence of TGF-β . The full length RUNX3 did not notablyinhibit growth of these cell lines while, the N-t and RD truncates showed different trends inthese cell lines. Cell proliferation in the TGF-β impaired context cell lines (AGS and MCF-7)significantly decrease while in the A549 significantly increase. On the other hand, transfectionof N-t and RD did not considerably affect the cell proliferation in the HEK293. Our results showthat full-lenght RUNX3 did not affect the cell viability. Conversely, the N-t and RD constructssignificantly changed cell proliferation. Therefore, therapeutic potentials for these truncatedproteins are suggested in tumors with RUNX proteins dysfunction, even in the TGF-β impaircontext.